project id: TCGA-UCEC; case submitter id: TCGA-KP-A3W0; source center: 23; state: released; a260 a280 ratio: 1.85; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.5; rna integrity number: 8.9; age at index: 72; days to birth: -26378; ethnicity: not reported; gender: female; race: not reported; vital status: Alive; year of birth: 1939; age at diagnosis: 26378; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 404.0; figo stage: Stage IB; icd 10 code: C54.1; last known disease status: not reported; morphology: 8441/3; primary diagnosis: Serous cystadenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Endometrium; synchronous malignancy: No; tissue or organ of origin: Endometrium; tumor grade: Not Reported; year of diagnosis: 2011; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 351; initial weight: 90.0; sample id: 570bb596-bad8-4a83-a7d7-e9fa8c9e16aa; sample submitter id: TCGA-KP-A3W0-01A; portion id: 246029f0-0e22-4f73-baa5-eb80d889d8e7; portion submitter id: TCGA-KP-A3W0-01A-21; slide id: e56865fe-8c27-4dbb-8c65-4f35e433cb5f; slide submitter id: TCGA-KP-A3W0-01A-02-TSB; percent lymphocyte infiltration: 60.0; percent monocyte infiltration: 20.0; percent necrosis: 10.0; percent neutrophil infiltration: 10.0; percent normal cells: 0.0; percent stromal cells: 30.0; percent tumor cells: 60.0; percent tumor nuclei: 60.0; section location: TOP;